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ABSTRACT
5
Orthostatic intolerance remains a sign_ificant problem following
space flight despite frequent use of the saline fluid-loading
countermeasure and volitional use of an anti-gravity suit during re-
entry and landing. The purpose of this project is to examine the
plasma volume (PV), endocrine, and orthostatic responses of bed-
rested subjects following 2-hr and 4-hr treatments of lower body
negative pressure (LBNP) and saline ingestion. Ten healthy men (25
to 41 yrs) underwent 13 days of 6 o head-down bed rest. The men
were randomly assigned into 2 groups. Group A underwent a 4-hr
LBNP]saline treatment on bed rest day 5 and the 2-hr treatment on
day |l. Group B underwent the 2-hr treatment on day 6 and the 4-
hr treatment on day 10. Blood volume was determined before and
after bed rest using radiolabelling. Changes in PV between
measurements were calculated from changes in hematocrit and
estimated red cell volume. Urinary excretion of anti-diuretic
hormone (ADH) and aldosterone (ALD) were measured each day
during the study. Orthostatic responses were measured using a ramp
LBNP protocol before bed rest, before each treatment, and 24 hours
after each treatment. Both 2-hr and 4-hr treatments resulted in a
restoration of PV to pre-bed rest levels which persisted at least 24
hours. This increase in PV was associated with significant increases
in urinary excretion of ADH and ALD. Twenty-four hours after the
4-hr treatment, the heart rate and pulse pressure response to LBNP
were significantly lower and stroke volumes during LBNP were
increased. Twenty-four hours after the 2-hr treatment, there was no
evidence of improvement in orthostatic responses. These results
suggest that a countermeasure which simply restores PV during
space flight may not be sufficient for restoring orthostatic responses.
INTRODUC_ONANDBACKGROUND:
LBNP has been used as a procedure to assess orthostatic
responses postflight in the Apollo program (1), and in flight during
the Skylab program (2). In the Soviet space program LBNP is
routinely used inflight both as an assessment procedure and as a
countermeasure for postflight orthostatic intolerance (3,4).
Cosmonauts perform the LBNP countermeasure while wearing a
flexible LBNP suit (the Chibis suit). The LBNP exposures are begun 5
to 21 days before landing, depending on the mission duration, and
are combined with fluid and salt ingestion. There is no data
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available from the Soviet flight experience which would reveal the
precise mechanism by which their LBNP countermeasure acts to
improve orthostatic responses.
American research into the possible use of LBNP as a
countermeasure began in the 1960s. Lamb and Stevens (5), Stevens
et. al (6), and McCally et. al (7) performed studies indicating that
prolonged exposures (8-12 hrs daily) to LBNP during bed rest could
maintain body fluid balance (5), plasma volume (6), and orthostatic
responses (6,7). Hyatt and West (8) were the first to combine the
LBNP exposure with fluid ingestion. They reported a restoration of
plasma volume and significantly reduced heart rate and blood
pressure changes during LBNP, in men after 7 days of bed rest. They
concluded that the improvement in orthostatic responses was most
likely the result of the increased plasma volume and that further
work was required to determine the minimum exposure duration
required to provide such improvements.
PURPOSE AND HYPOTHESES:
The operational purpose of this project is to determine whether
the LBNP/saline countermeasure proposed by Hyatt and West (8)
may be reduced to 2 hours and still maintain the beneficial effects on
plasma volume and orthostatic responses. In answering this
question, we hope to gain a better understanding of potential
mechanisms for the loss of orthostatic function during a simulated
space flight-- 13 day bed rest--and a greater understanding of the
specific mechanisms by which prolonged LBNP during bed rest may
reverse some of these changes.
We hypothesize that during prolonged LBNP exposures, fluid is
redistributed from the thoracic region of the body to the lower body,
thus stimulating cardiopulmonary mechanoreceptors. The unloading
of these receptors due to the decrease in central blood volume
results in an increased secretion of ADH and ALD. Increased levels of
ADH and ALD result in fluid and electrolyte retention during the 24
hour period after the LBNP/saline countermeasure. In addition, the
accumulation of fluid in the lower body during LBNP may result in
the filtration and sequestration of fluid in the lower body tissues.
This fluid is later reabsorbed, and in the presence of elevated ADH
and ALD may contribute to the plasma volume expansion. The
restoration of plasma volume will result in a larger stroke volume,
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lower heart rates, higher blood pressures, and a larger cardiac output
during a graded orthostatic stress such as LBNP.
L
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METHODS AND PROCEDURES:
Ten men (25 to 40 yrs; 169 to 182 cm. height; 66 to 90 kg
weight; and 45 to 59 ml/min/kg maximum oxygen consumption)
participated in this study.
The study protocol involved a crossover design with the
subjects randomly assigned to two groups, group A and group B. The
experimental protocol is shown in Figure 1. Each subject was
exposed to one 4-hr and one 2-hr LBNP/saline treatment, with half
the subjects exposed to the 4-hr treatment first and the 2-hr
treatment second (group A), and the other half exposed to the 2-hr
treatment first and the 4-hr treatment second (group B). During
each treatment, the subject was exposed to a continuous negative
pressure exposure of -30 mm Hg and ingested one liter of isotonic
saline between exposure minutes 30 and 90.
Blood volume was calculated as the sum of red cell volume
(RCV) and PV measurements obtained before and on the last day of
bed rest. RCV was determined with 51chromium sulfate and PV was
determined with 125iodinated human serum albumin. PV was
calculated for each bed rest day from the daily RCVd (RCVd = pre
bed rest RCV minus the accumulative loss of red cells due to daily
blood draws) and the daily hematocrit value; where PV =
(RCVd/(hct/100)) RCVd.
Pre-syncopal LBNP tests (graded LBNP exposures in 3 min.
stages which continued until pre-syncopal symptoms were observed)
were done before and after bed rest. LBNP response tests (graded
LBNP exposures in 5 min. stages from 0 to -60 mm Hg in 10 mm Hg
steps) were performed pre-bed rest, before each treatment, and 24
hours after each treatment.
V
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Each subject underwent a 13-day, 6 ° head-down bed rest, two
days of ambulatory control before bed rest, and two days of
ambulatory recovery after bed rest. Throughout bed rest fluid, salt,
and food intake were maintained at 2500 ml of rehydration
fluid/day, 4 grams of salt/day, and 2500 Kcal/day. Twenty-four
hour urine collections were obtained each day of the study from
which volume, electrolytes, ADH, and ALD concentration were
measured. Venous blood samples were obtained without stasis each
morning and before each LBNP test. Hematocrit and hemoglobin
concentration were determined from each sample.
RESULTS AND DISCUSSION:
A. Pre-syncopal LBNP Results--Pre vs. Post Bed Rest
The effect of 13 days of bed rest on LBNP tolerance is shown in
Figure 2; where "LBNP tolerance" is defined as the LBNP pressure
tolerated for at least one minute without pre-syncopal symptoms.
Not all subjects had a decrease in LBNP tolerance during bed rest and
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there was no significant correlation between changes in LBNP
tolerance and changes in blood volume (nieasured viar-radiolabelling
on the morning of PSL-LBNP testing). However, there was a
significant correlation between the the change in LBNP tolerance
during bed rest and the pre-bed rest LBNP tolerance (Figure 3).
Subjects with high LBNP tolerance had a greater decrease in LBNP
tolerance during bed rest than subjects with low LBNP tolerance.
FIGURE 2
Lowest Pressure Attained, Pre vs. Post Bed Rest
12)
"I"
E
E
in
m
P
a.
a.
m
,,.J
(D
3
0
--I
° I
O.
l prebr tol
[] I_lt br tot
% Change In BV
1 2 3 4 s 6 7 s g 10
Individual Subjects
FIGURE 3
Change in LBNP Toleranc_ as a Function
of Pre-Bed RHt Tolerance
10
ell
y : 26.6M * 0.48315x RA2 : O,SU
c
._ .lo
e
c_ -20 f • • Q
-30
U
-40
-120"-(10"-,;0"-gO "-80 "-iO --iO "-50
Pro-Bed Rest Tolerance, mmHg
B. Changes in Plasma Volume During Bed Rest--Effect of the 2-hr
and 4-hr LBNP and saline ingestion treatments.
The changes in PV determined from each morning blood
sample are shown in Figure 4 for Group A and in Figure 5 for Group
B. In both groups, PV decreased initially during bed rest and
returned towards the pre-bed rest level for one to two days
following each LBNP treatment.
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FIGURE 4
% Change In Plasma Volume, group •
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C. ADH, ALD, and PV during Bed Rest: effect of LBNP and saline
ingestion"
There were no significant differences between the two groups
in any of the treatement or bed rest responses (analysis of variance).
Therefore, the data from both groups was combined to compare the
effect of the LBNP and saline ingestion treatments on PV, endocrine,
and orthostatic responses. PV was calculated from blood samples
drawn immediately before each LBNP response test and ADH and
ALD secretion were determined from 24-hr urine samples (Table 1).
PV was significantly reduced from pre-bed rest levels before each
LBNP treatment, but, 24 hours after each treatment PV was no
longer significantly different from pre bed rest. On the day of each
LBNP treatment, there was a significant increase in the secretion of
both ADH and ALD (compared to pre-treatment) which may have
contributed to the plasma volume expansion.
TABLE 1
Variable
PV (ml)
UV (ml)
ADH (ng)
ALD (ng)
PreBR Pre 4hr Post 4hr Pre 2hr Pe_t 2hr
3157(161) "2918(132)3144(173) "2987(131)3109(146)
2506(250) 2538(155) +2923(111) 2258(162) +2788(191)
136(33) 114 (15) +177 (26) 93 (18) +155 (42)
16(4) *35(4) +*54(5) *37(7) +*46(7)
* = Different from pre bed rest, P <0.05.
+ = Different from pre treatment (pre 4hr or pre 2hr), P < 0.05.
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D. Orthostatic Responses during Bed Rest--effect of LBNP and saline
treatments" V
The results in Table 2 illustrate the orthostatic responses
(mean + S.E.) for all 10 subjects by presenting specific cardiovascular
variables during the final (-60 mm Hg) LBNP exposure level. Heart
rates were significantly higher than pre bed rest during all pre and
post LBNP treatment tests, although post treatment, the heart rates
were lower than pre treatment. Pulse pressure was significantly
reduced during bed rest without LBNP treatment but not after
treatment. Stroke volume was reduced significantly during bed rest
without treatment, but not following treatment. Cardiac output
(measured by continuous wave Doppler at the suprasternal notch)
was not affected by either bed rest or LBNP treatment.
TABLE 2
Variable Pre-BR
Heart rate (bpm) 111 (5)
Pulse Pressure (mm Hg) 25 (3)
Cardiac Output (I/min) 4.2 (0.4)
Stroke Volume (ml/beat) 39 (5)
Pre-4hr Post-4hr Pre-2hr P0st-2hr
"134 (4) "128 (5) "144 (5) "134 (5)
"16(2) 19 (2) "18 (3) 19 (3)
3.7 (0.2) 3.8 (0.4) 3.6 (0.3) 4.0 (0.3)
*27 (2) 29 (3) *27 (3) 29 (3)
* = Different from pre bed rest value, P < 0.05.
V
Figures 6 and 7 illustrate the mean + S.E. heart rate response to
the entire LBNP ramp test (0 to -60 mm Hg) and they compare this
response pre bed rest, during bed rest before treatment (pre 2-hr
and pre 4-hr) and 24 hours after the 4-hr and 2-hr treatments.
After the 4-hr treatment, the heart rate response was
significantly elevated from pre-bed rest, but significantly improved
from pre treatment (pre 4-hr). The effectiveness of the treatment to
lower heart rate diminished with increasing LBNP exposure.
After the 2-hr treatment, the heart rate response was
significantly elevated from pre bed rest and there was no significant
improvement after the treatment.
V
68
FIGURE 6 FIGURE 7
Effect of 4hr Soak
A
II
Z
Pre 4hr I
24 Poet 4hr
Pro br
..11 =. webr
Fe4h_
24¢od 4t,r
n=10
1Go
140
E
,a
12o
10o
1::
i
o
8o
rm
Effect of 2 hr Soak
pro 2hr
Post 2hr [
Pro br
,--_'''_ n=10
8o
vorep4_mm.= O, tm from "brlv" Ibnp pressure
- , - ,
20 " 40 60 80
CONCLUSIONS:
1) The loss of tolerance to LBNP after 13 days of bed rest is most
marked in individuals with high LBNP tolerance pre bed rest.
2) Prolonged LBNP exposures during bed rest effectively increase PV
for at least 24 hours and this expansion may be related to an
increased secretion of ADH and ALD.
3) 4-hr LBNP exposures combined with salt water ingestion may
provide some improvement of orthostatic responses for
approximately 24 hours. 2-hr exposures are less effective.
SIGNIFICANCE:
Prolonged LBNP and saline ingestion may provide an effective
means to restore PV during space flight. However, with this
particular protocol (LBNP pressure and fluid ingestion) a 2 hour LBNP
exposure is not sufficient to restore orthostatic responses.
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